Entities / Entity
Cellectis.
biopharmaceutical company
- Reports this week
- 1
- Active events
- 1
- Connections
- 10
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Cellectis this week
News at the entities that move Cellectis most-
SEC StructuralDHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Moves Cellectis
-
MarketBeat Mentioned togetherApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Cellectis
-
New York City Shared contextJoint entities are driving a high volume of General Obligation bond issuance in New York City.Moves Cellectis
-
Nasdaq StructuralAppLovin stock is traded on Nasdaq, and both AppLovin and Trade Desk operate in the competitive digital advertising technology landscape.Moves Cellectis
Connections
The 5 strongest of 10, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Nasdaq Structural
Cellectis operates as a publicly traded company whose stock listing and trading are dependent on the Nasdaq exchange infrastructure.
-
SEC Structural
Cellectis operates under the regulatory oversight of the SEC, requiring the filing of mandatory reports.
-
Nitin Jain Operational
Nitin Jain is actively involved in presenting and discussing Cellectis's clinical trial data.
-
MarketBeat Mentioned together
MarketBeat reports Cellectis's average rating.
-
New York City Shared context
Cellectis is associated with an investigation reported from New York City.